Smoking Crushed Hyoscine/Scopolamine Tablets as Drug Abuse

REFERENCES

• Afshari, R., Majdzadeh, R., & Balali-Mood M. (2004). Pattern of acute poisonings in Mashhad, Iran 1993–2000. Journal of Toxicology—Clinical Toxicology (JournalSeek), 42(7), 965–975.
   PubMed Web of Science ®Google Scholar
• Afshari, R., Shafaeeyan, H., & Afshari, R. (2006).An epidemiologic study of opioid dependent subjects who were volunteered for opioid detoxification in Iran in 2005. Journal of Toxicology—Clinical Toxicology (JournalSeek), 44,4; 581–582.
   Google Scholar
• Américo, M. F., Miranda, J. R., Corá, L. A., & Romeiro, F. G. (2009). Electrical and mechanicaleffects of hyoscine butylbromide on the human stomach: A non-invasiveapproach. Physiological Measurement, 30(4), 363–370.
   Google Scholar
• Ayub, N., Donaldson, D., Bedford, D., Alloway, R., & Ryalls, M. (1997). Lessons to be learned: A case study approach. Hyperactivity and confusion in the presentation of hyoscine overdose. Journal of the Royal Society of Health, 117(4), 242–244.
   Google Scholar
• Barcia, E., Martín, A., Azuara, M. L., Sánchez, Y., & Negro, S. (2007). Tramadol and hyoscine N-butylbromide combined in infusion solutions: Compatibility and stability. Support Care Cancer, 15(1), 57–62.
   Google Scholar
• Carmela, E., & Corallo Ann. (2009). Anticholinergic syndrome following an unintentional overdose of scopolamine. Therapeutics and Clinical Risk Management, 5, 719–723.
   Google Scholar
• Centers for Disease Control and Prevention. (1996). Scopolamine poisoning among heroin users–New York City, Newark, Philadelphia, and Baltimore, 1995 and 1996. The Journal of the American Medical Association, 276(2), 92–93.
   Google Scholar
• Frascht, M., Schneider, S., Lemmer, P., Schuman, M., & Wennig, R. (2007). Getting High by Smoking Hyoscine Butylbromide?! The annual meetings of International Council on Alcohol, Drugs, and Traffic Safety (ICADTS) (pp. 26–30). Seattle, Washington.
   Google Scholar
• Gregory, M. D., Mersfelder, T. L., & Jamieson, T. (2010). Accidental overdose of tiotropium in a patient with atrial fibrillation. Annals of Pharmacotherapy, 44(2), 391–393.
   PubMed Web of Science ®Google Scholar
• Hamilton, R. J., Perrone, J., Hoffman, R., Henretig, F. M., Karkevandian, E. H., Marcus, S., (2000). A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. Journal of Toxicology - Clinical Toxicology, 38(6), 597–608.
   PubMed Web of Science ®Google Scholar
• Hamilton, R., Perrone, J., Meggs, W., Jolian, A., Trachtenberg, J., Zhang, Y., (1995). Epidemic anticholinergic poisoning from scopolaminetainted heroin. Journal of Toxicology - Clinical Toxicology, 33, 502.
   Google Scholar
• Hernández Bueno, J. A., de la Jara Díaz, J., Sedeño Cruz, F., & Llorens Torres, F. (1998). Analgesic-antispasmodic effect and safety of lysine clonixinate and L-hyoscinbutylbromide in the treatment of dysmenorrhea. Ginecología y Obstetricia de México, 66, 35–39.
   Google Scholar
• Holdgate, A., & Oh, C. M. (2005). Is there a role for antimuscarinics in renal colic? A randomized controlled trial. Journal of Urology, 174(2), 572–575.
   Google Scholar
• Kasper, S., & Resinger, E. (2003). Cognitive effects and antipsychotic treatment. Psychoneuro-Endocrinology, 28, 27–38.
   PubMed Web of Science ®Google Scholar
• Lieberman, J. A. (2004). Managing anticholinergic side effects, Prim Care Companion. Journal of Clinical Psychiatry, 6(Suppl 2), 20–23.
   Google Scholar
• McEvoy, J. (1983). The clinical use of anticholinergic drugs as treatment for extrapyramidal side effects of neuroleptic drugs. Journal of Clinical Psychopharmacology, 3, 288–302.
   Web of Science ®Google Scholar
• Mueller-Lissner, S., Tytgat, G. N., Paulo, L. G., Quigley, E. M., Bubeck, J., Peil, H., (2006). Placebo- and paracetamolcontrolled study on the efficacy and tolerability of hyoscine butylbromide in the treatment of patients with recurrent crampy abdominal pain. Alimentary Pharmacology & Therapeutics, 23(12), 1741–1748.
   Google Scholar
• Musshoff, F., Trafkowski, J., Lichtermann, D., & Madea, B. (2010). Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs. International Journal of Legal Medicine, 124(5), 499–503.
   Google Scholar
• Noori, R., Narenjiha, H., Aghabakhshi, H., Habibi, G., & Khoshkrood Mansoori, B. (2012). Methadone maintenance therapy outcomes in Iran. Substance Use & Misuse, 47(7), 767–773.
   PubMed Web of Science ®Google Scholar
• Samuels, L. A. (2009). Pharmacotherapy Update: Hyoscine Butylbromide in the treatment of abdominal spasms clinical medicine. Citation: Clinical Medicine: Therapeutics, 1, 647–655
   Google Scholar
• Sirohiwal, D., Dahiya, K., & De, M. (2005). Efficacy of hyoscine-N-butylbromide (Buscopan) suppositories as a cervical spasmolytic agent in labor. Australian and New Zealand Journal of Obstetrics and Gynaecology, 45(2), 128–129.
   PubMed Web of Science ®Google Scholar
• Talbott, J. A., Halesk, E., & Yudofsky, S. C. (1998). The American Psychiatric Press Textbook. Washington, DC: American Psychiatric Press, Inc; .
   Google Scholar
• Tashakori, A., & Afshari, R. (2010). Tramadol Overdose as a cause of Serotonin Syndrome: A case series. Clinical Toxicology (Phila), 48(4), 337–341.
   PubMed Web of Science ®Google Scholar
• Thomas, L., Webb, C., Duvvi, S., Jones, T., & Reddy, K. T. (2005). Is buscopan effective in meat bolus obstruction? Clinical Otolaryngology 30(2), 183–185.
   Google Scholar
• Tytgat, G. N. (2008). Hyoscine butylbromide—a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures. Current Medical Research and Opinion, 24, 3159–3173.
   PubMed Web of Science ®Google Scholar
• Van Sassenbroeck, D. K., Hemelsoet, D. M., Vanwalleghem, P., Verstraete, A. G., Santens, P., Monsieurs, K. G., (2005). Three cases of substitution errors leading to hyoscine hydrobromide overdose. Clinical Toxicology (Phila), 43(7), 861–865.
   Web of Science ®Google Scholar
• Weiser, T., & Just, S. (2009). Hyoscine butylbromide potently blocks human nicotinic acetylcholine receptors in SH-SY5Y cells. Neuroscience Letters, 450(3), 258–261.
   PubMed Web of Science ®Google Scholar